CytomX Therapeutics CTMX Common Stock Issuance Costs Included In Accrued Liabilities
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept ctmx:CommonStockIssuanceCostsIncludedInAccruedLiabilities.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's common stock issuance costs included in accrued liabilities.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CytomX Therapeutics's common stock issuance costs included in accrued liabilities?
- CytomX Therapeutics (CTMX) reported common stock issuance costs included in accrued liabilities of $780K in Q1 2026.